Information:
Error:
ID
41386
Description
Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755
Link
https://clinicaltrials.gov/show/NCT01925755
Keywords
Versions (2)
- 1/19/19 1/19/19 -
- 9/28/20 9/28/20 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
September 28, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Stroke Secondary to Atrial Fibrillation, NCT01925755
Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755
- StudyEvent: Eligibility
Similar models
Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age, Gender, Start of Rivaroxaban
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
Non-valvular Atrial fibrillation
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
C0004238 (UMLS CUI [1,1])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Tia/stroke history
Item
prior tia/stroke history
boolean
C0559159 (UMLS CUI [1])
C0455536 (UMLS CUI [2])
C0455536 (UMLS CUI [2])
Tia more than 72 hours ago
Item
if tia - more than 72 hours after documented tia
boolean
C0231290 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
C0007787 (UMLS CUI [1,2])
Non-hemorrhagic stroke more than 2 weeks ago
Item
if stroke - more than 2 weeks after non-hemorrhagic stroke
boolean
C0038454 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0231290 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Contraindications Xarelto®
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
C1739768 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0522473 (UMLS CUI [1,2])
Anticoagulant prophylaxis for stroke/tia prevention
Item
previous thromboprophylaxis treatment for stroke/tia prevention
boolean
C0199242 (UMLS CUI [1])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
Other reason affecting participation
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean
C3840932 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])